Browsing Category

63855 posts
"LG Innotek is Advancing the Future of Mobility with 'Sensing, Communication, and Lighting Solutions'

"LG Innotek is Advancing the Future of Mobility with 'Sensing, Communication, and Lighting Solutions'

The LG Innotek booth at CES 2024 welcomed a record-breaking sixty thousand…
International Copper Association Welcomes New President and CEO

International Copper Association Welcomes New President and CEO

WASHINGTON, Jan. 17, 2024 /PRNewswire/ — The Board of the International Copper…
Rising Food Prices Will Not Prompt Another RBI Hike

Rising Food Prices Will Not Prompt Another RBI Hike

Key View The Reserve Bank of India kept its monetary policy settings…
DJI Mic 2: Elevating Professional Audio Recording Excellence

DJI Mic 2: Elevating Professional Audio Recording Excellence

with Unparalleled Quality, User-Centric Design, and Exceptional Stability SHENZHEN, China, Jan. 17,…
TÜV Rheinland Issues "Perceptual Color Volume" Certification to Lenovo™'s New Yoga™ Pro 9i Laptop

TÜV Rheinland Issues "Perceptual Color Volume" Certification to Lenovo™'s New Yoga™ Pro 9i Laptop

SHANGHAI, Jan. 17, 2024 /PRNewswire/ — TÜV Rheinland Group, an international independent…
Visionlink Media: A Magnificent Art Exhibition About The Yangtze River In Nanjing To Visit Right Now

Visionlink Media: A Magnificent Art Exhibition About The Yangtze River In Nanjing To Visit Right Now

NANJING, China, Jan. 17, 2024 /PRNewswire/ — "This Is The Yangtze River" Digital…
SurplusGLOBAL, Global Parts Platform Business Gains Traction

SurplusGLOBAL, Global Parts Platform Business Gains Traction

Expansion of ‘Global Parts Platform’ service for global semiconductor companies SEOUL, South…
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

– Data from first tranche of MSS CRC patients treated with ADG126…